A Study of Tumor Neoantigen-specific T Cells in the Treatment of Advanced Solid Tumors
Clinical trial NCT06431529 · UNKNOWN
Trial details
- NCT number
- NCT06431529
- Sponsor
- JIANG LONGWEI
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-18
- Primary completion
- 2025-03-31
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.